April 02, 2019 Corporate and Business News

• BerGenBio: Preclinical Data Presented at AACR Reinforces Bemcentinib's Potential to Reverse Tumour Immunosuppression and Therapy Resistance

• Nordic Nanovector: Promising Results From Preclinical Studies With a Novel CD37-targeted Alpha Therapy for B-cell Tumours Presented at TAT11

• Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results

• Back to Home

• Archive History